C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer

scientific article published on 06 March 2018

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/2162402X.2018.1433517
P932PMC publication ID5980413
P698PubMed publication ID29872564

P50authorJiejie XuQ87993892
P2093author name stringHao Liu
He Li
Heng Zhang
Jing Qin
Zhenbin Shen
Hongyong He
Yifan Cao
Songyang Wu
Rochen Li
P2860cites workHuman macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cellsQ24321607
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyQ27002646
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.Q48099359
Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.Q48626617
C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.Q50650527
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells.Q51049738
Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray.Q54674032
Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancerQ70511127
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinomaQ81351659
Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppressionQ83735256
Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1Q84418006
Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resectionQ85330142
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancerQ85722982
GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinomaQ87759994
Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institutionQ87885346
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAsQ110949771
Innate and adaptive immune cells in the tumor microenvironmentQ27008342
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerQ27853326
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivoQ28203975
Comprehensive molecular characterization of gastric adenocarcinomaQ28244985
The future of immune checkpoint therapyQ28259862
Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responsesQ28302398
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalQ29547865
Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implicationsQ31059425
Family history and the risk of gastric cancerQ33630778
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemiaQ33688225
American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working GroupQ33875909
Macrophage-derived chemokine (MDC).Q34031541
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapseQ34171959
The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spotsQ34256831
Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunityQ34495723
Increase of regulatory T cells in the peripheral blood of cancer patients.Q34531138
Chemotherapy for advanced gastric cancer: across the years for a standard of careQ34617795
Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival timeQ35772513
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.Q35912196
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphomaQ36288217
Neo-adjuvant and adjuvant chemotherapy of gastric cancerQ36860125
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.Q37346143
High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironmentQ37650692
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancerQ37711697
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.Q38667837
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.Q38830643
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activityQ39156200
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialQ40046733
Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-betaQ40160226
Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancerQ40365739
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinomaQ41792382
Synergy-inducing chemokines enhance CCR2 ligand activities on monocytesQ43588267
Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophilsQ46333876
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.Q46373510
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.Q47131106
Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgeryQ47652727
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.Q47975537
ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitisQ48026306
P433issue6
P921main subjectchemotherapyQ974135
P304page(s)e1433517
P577publication date2018-03-06
P1433published inOncoImmunologyQ18026500
P1476titleC-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer
P478volume7

Reverse relations

cites work (P2860)
Q89724967CCL22 Signaling in the Tumor Environment
Q92593617Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment
Q92013108Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
Q64103418M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
Q90106921Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer

Search more.